Magnasense will create technology for biomarker assays that are easily accessible.
Magnasense has raised $711K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in April 2024.
Magnasense's investors include National Institutes of Health.
Magnasense is headquartered in La Jolla, United States.
Magnasense will create technology for biomarker assays that are easily accessible.
Magnasense is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Magnasense — Funding & Investors." VCBacked, April 9, 2024, https://www.vcbacked.co/company/magnasense. Accessed July 19, 2026.
VCBacked. (2024). Magnasense — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/magnasense
{{cite web |title=Magnasense — Funding & Investors |url=https://www.vcbacked.co/company/magnasense |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated